R162

CAS No. 64302-87-0

R162( R162 | R 162 | R-162 )

Catalog No. M17560 CAS No. 64302-87-0

R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
5MG 38 In Stock
10MG 69 In Stock
25MG 154 In Stock
50MG 253 In Stock
100MG 420 In Stock
200MG 606 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    R162
  • Note
    Research use only, not for human use.
  • Brief Description
    R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.
  • Description
    R162 is an inhibitor of GDH activity and represses glioma cell growth.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    R162 | R 162 | R-162
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    glutamate dehydrogenase 1 (GDH1)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    64302-87-0
  • Formula Weight
    264.28
  • Molecular Formula
    C17H12O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL; 378.39 mM
  • SMILES
    O=C(C1=C2C=CC=C1)C3=CC=C(CC=C)C(O)=C3C2=O
  • Chemical Name
    2-Allyl-1-hydroxy-anthraquinone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jin L, et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell. 2015 Feb 9;27(2):257-70.
molnova catalog
related products
  • Panitumumab

    Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).

  • PD-161570

    PD-161570 is a potent and ATP-competitive human FGF-1 receptor inhibitor with an IC50 of 39.9 nM and a Ki of 42 nM. PD-161570 also inhibits the PDGFR, EGFR and c-Src tyrosine kinases with IC50 values of 310 nM, 240 nM, and 44 nM, respectively.

  • EAI001

    EAI001 is a potent and selective mutant epidermal growth factor receptor (EGFR) variant inhibitor that inhibits EGFRL858R/T790M with an IC50 value of 24 nM.EAI001 can be used in cancer research.